Lophius Biosciences GmbH:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Lophius Biosciences GmbH - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10389
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lophius Biosciences GmbH (Lophius) is a biotechnology company that develops and markets T cell-based diagnostic systems and research tools in the areas of transplantation, infectious and autoimmune diseases. The company’s T-track immunoscan assay is a test in natural or induced immune modulation to evaluate the functionality of cell mediated immunity. Its T-track CMV is a diagnostic test to measure CMV-specific cell mediated immunity. Lophius provides T cell tools such as ELISpot kits, T cell stimulants, and custom ELISpot kit. The company offers services including antigen selection, optimization, immune assay development and therapy monitoring. It markets its products through its specialized marketing and distribution partners in Germany, Spain, the Netherlands, Belgium, Luxemburg and Korea. Lophius is headquartered in Regensburg, Germany.

Lophius Biosciences GmbH – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lophius Biosciences GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Lophius Biosciences GmbH, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Lophius Biosciences GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Lophius Biosciences GmbH, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Lophius Biosciences GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Lophius Biosciences GmbH, Medical Equipment, Deal Details 10
Venture Financing 10
Lophius Biosciences Raises USD2.4 Million in First Tranche of Venture Financing 10
Lophius Biosciences Raises USD4.66 Million in Venture Financing 11
Lophius Biosciences Raises Funds through Venture Financing 12
Lophius Biosciences Raises US$2.8 Million In Venture Financing 13
Lophius Biosciences Raises USD5.3 Million in Series C Financing Round 14
Partnerships 15
Oxford Immunotec Enters Into Licensing Agreement With Lophius Biosciences For Urea Technology 15
Oxford Immunotec Enters Into Licensing Agreement With Lophius Biosciences For T-Spot Technology 16
Lophius Biosciences Enters into Agreement with BL&H 17
Lophius Biosciences GmbH – Key Competitors 18
Lophius Biosciences GmbH – Key Employees 19
Lophius Biosciences GmbH – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
Mar 22, 2017: Lophius Biosciences Appoints Robert J. Silverman as Supervisory Board Member 21
Other Significant Developments 22
May 31, 2017: Lophius Biosciences Receives Public Grant for the Development of an Advanced Diagnostic Tuberculosis Test 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Lophius Biosciences GmbH, Medical Equipment, Key Facts 2
Lophius Biosciences GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Lophius Biosciences GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Lophius Biosciences GmbH, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Lophius Biosciences GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Lophius Biosciences GmbH, Deals By Market, 2012 to YTD 2018 8
Lophius Biosciences GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Lophius Biosciences Raises USD2.4 Million in First Tranche of Venture Financing 10
Lophius Biosciences Raises USD4.66 Million in Venture Financing 11
Lophius Biosciences Raises Funds through Venture Financing 12
Lophius Biosciences Raises US$2.8 Million In Venture Financing 13
Lophius Biosciences Raises USD5.3 Million in Series C Financing Round 14
Oxford Immunotec Enters Into Licensing Agreement With Lophius Biosciences For Urea Technology 15
Oxford Immunotec Enters Into Licensing Agreement With Lophius Biosciences For T-Spot Technology 16
Lophius Biosciences Enters into Agreement with BL&H 17
Lophius Biosciences GmbH, Key Competitors 18
Lophius Biosciences GmbH, Key Employees 19

List of Figures
Lophius Biosciences GmbH, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Lophius Biosciences GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Lophius Biosciences GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Lophius Biosciences GmbH, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Lophius Biosciences GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Lophius Biosciences GmbH, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Lophius Biosciences GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Lophius Biosciences GmbH, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Lophius Biosciences GmbH:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Grid2020, Inc.-エネルギー分野:企業M&A・提携分析
    Summary Grid2020, Inc. (Grid2020) is a provider of smart grid solutions. The company offers an integrated distribution transformer monitoring solutions under the brand Optanode. The Optanode product family consists of sensors and smart analytics software and provides information about the distributi …
  • Brown-Forman Corporation:企業の戦略・SWOT・財務分析
    Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report Summary Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Malayan Banking Berhad:企業のM&A・事業提携・投資動向
    Malayan Banking Berhad - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Malayan Banking Berhad Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Nabors Industries Ltd.:戦略・SWOT・企業財務分析
    Nabors Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nabors Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Kesko Corp (KESKOA):企業の財務・戦略的SWOT分析
    Kesko Corp (KESKOA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Frontline Ltd (FRO):企業の財務・戦略的SWOT分析
    Frontline Ltd (FRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Taiwan Cogeneration Corp (8926):企業の財務・戦略的SWOT分析
    Summary Taiwan Cogeneration Corp (Taiwan Cogeneration) is a power company that offers power and electrical energy generation and cogeneration services. The corporation provides services such as construction, investment, operation, and management of power and energy generation cogeneration plants in …
  • Enel SpA (ENEL):電力:M&Aディール及び事業提携情報
    Summary Enel SpA (Enel) is an integrated electricity and gas company that produces, distributes and trades electricity and natural gas. The group generates electricity using diverse sources of energy such as nuclear, renewables, oil and gas turbine, coal and gas combined cycle. It also focuses on di …
  • Regeneron Pharmaceuticals Inc (REGN):企業の製品パイプライン分析
    Summary Regeneron Pharmaceuticals Inc (Regeneron) discovers, develops, manufactures, and markets medicines for the treatment of serious medical conditions. Its marketed and pipeline products are focused on helping patients suffering with eye diseases, cancer, allergic and inflammatory diseases, meta …
  • Citibank NA-India Branches:企業の戦略的SWOT分析
    Citibank NA-India Branches - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Fuji Seal International Inc.:企業の戦略・SWOT・財務情報
    Fuji Seal International Inc. - Strategy, SWOT and Corporate Finance Report Summary Fuji Seal International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • NantKwest Inc (NK):製薬・医療:M&Aディール及び事業提携情報
    Summary NantKwest Inc (NantKwest), a subsidiary of NantWorks LLC, formerly Conkwest Inc, is a clinical-stage immunotherapy company that develops therapeutic treatments for cancer, infectious diseases, and inflammatory diseases. The company utilizes its immuno-oncology NK platform to destroy the tumo …
  • Worldpay Group Ltd:企業の戦略・SWOT・財務分析
    Worldpay Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Worldpay Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Energen Corporation:企業の戦略・SWOT・財務情報
    Energen Corporation - Strategy, SWOT and Corporate Finance Report Summary Energen Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Stockland Corporation Ltd:企業のM&A・事業提携・投資動向
    Stockland Corporation Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Stockland Corporation Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Emperor Energy Ltd (EMP):石油・ガス:M&Aディール及び事業提携情報
    Summary Emperor Energy Ltd (Emperor Energy), formerly Oil Basins Ltd, is an oil and gas company that explores, produces, and develops crude oil and natural gas properties. The company explores oil and gas properties in onshore Canning Basin of Western Australia, offshore Gippsland Basin waters of so …
  • ToolGen Inc-製薬・医療分野:企業M&A・提携分析
    Summary ToolGen Inc (ToolGen) is a genome editing company that concentrates on translating the genetic knowledge into transformative products for biomedicine and agriculture. The company creates intellectual property rights for essential tools and technologies for editing the genetic information in …
  • Cboe Global Markets, Inc (CBOE):企業の財務・戦略的SWOT分析
    Cboe Global Markets, Inc (CBOE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • QBE Insurance Group Limited:戦略・SWOT・企業財務分析
    QBE Insurance Group Limited - Strategy, SWOT and Corporate Finance Report Summary QBE Insurance Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Tokio Marine Holdings, Inc.:戦略・SWOT・企業財務分析
    Tokio Marine Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tokio Marine Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆